ES2103271T3 - Dispositivo para administrar un agente activo a la piel o a mucosas. - Google Patents

Dispositivo para administrar un agente activo a la piel o a mucosas.

Info

Publication number
ES2103271T3
ES2103271T3 ES90905296T ES90905296T ES2103271T3 ES 2103271 T3 ES2103271 T3 ES 2103271T3 ES 90905296 T ES90905296 T ES 90905296T ES 90905296 T ES90905296 T ES 90905296T ES 2103271 T3 ES2103271 T3 ES 2103271T3
Authority
ES
Spain
Prior art keywords
membrane
layer
backing
peelable
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90905296T
Other languages
English (en)
Inventor
Yunik Chang
Dinesh C Patel
Charles D Ebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23272639&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2103271(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theratech Inc filed Critical Theratech Inc
Application granted granted Critical
Publication of ES2103271T3 publication Critical patent/ES2103271T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Devices For Medical Bathing And Washing (AREA)

Abstract

DISPOSITIVO DE ABASTECIMIENTO DE DROGA TRANSDERMAL (11) QUE COMPRENDE UN RECIPIENTE CONTENEDOR DE FORMULACION DE DROGA (13) DEFINIDO MEDIANTE UNA CAPA DE APOYO (112) Y UNA CAPA DE MEMBRANA PERMEABLE A LA DROGA (16), UN REVESTIDOR INTERNO DESPEGABLE (20) QUE SE EXTIENDE DEBAJO DEL RECIPIENTE Y UNA PORCION DE EL APOYO LA MEMBRANA HACIA AFUERA DE LA PERIFERIA DEL RECIPIENTE, UNA CAPA ADHESIVA (15) QUE SE EXTIENDE DEBAJO DEL REVESTIDOR INTERNO Y DE LAS PORCIONES QUE SE EXTIENDEN HACIA AFUERA DE LAS CAPAS DE MEMBRANA/APOYO, Y UNA CAPA DE REVESTIDOR DE DESPRENDIMIENTO DESPEGABLE (17) QUE SE EXTIENDE DEBAJO DE LA CAPA ADHESIVA CON UN PRIMER SELLO TERMICO PERMANENTE (18) ENTRE EL APOYO Y LA MEMBRANA ALREDEDOR DEL PERIMETRO DEL RECIPIENTE Y OTRO SELLO TERMICO (IMPERMEABLE) DESPEGABLE (19) ENTRE LA MEMBRANA Y EL REVESTIDOR INTERNO QUE SE EXTIENDE DEBAJO DEL PRIMER SELLO TERMICO PERMANENTE, PROPORCIONANDO LOS SELLOS TERMICOS Y LA CAPA DE BARRERA DESPEGABLE BARRERAS QUE AISLAN LA FORMULACION DE LA DROGA DEL ADHESIVO.
ES90905296T 1989-03-21 1990-03-21 Dispositivo para administrar un agente activo a la piel o a mucosas. Expired - Lifetime ES2103271T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/326,536 US4983395A (en) 1987-11-12 1989-03-21 Device for administering an active agent to the skin or mucosa

Publications (1)

Publication Number Publication Date
ES2103271T3 true ES2103271T3 (es) 1997-09-16

Family

ID=23272639

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90905296T Expired - Lifetime ES2103271T3 (es) 1989-03-21 1990-03-21 Dispositivo para administrar un agente activo a la piel o a mucosas.

Country Status (11)

Country Link
US (1) US4983395A (es)
EP (1) EP0464106B1 (es)
JP (1) JPH0818976B2 (es)
KR (1) KR0149492B1 (es)
AT (1) ATE154751T1 (es)
AU (1) AU631417B2 (es)
CA (1) CA2053272C (es)
DE (1) DE69030974T2 (es)
DK (1) DK0464106T3 (es)
ES (1) ES2103271T3 (es)
WO (1) WO1990011065A1 (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5160741A (en) * 1990-07-06 1992-11-03 Alza Corporation Reduction or prevention of skin irritation by drugs
US5130139A (en) * 1990-07-06 1992-07-14 Alza Corporation Reduction or prevention of skin irritation by drugs
US5484604A (en) * 1990-07-21 1996-01-16 Chatfield Pharmaceuticals Limited Cross-linked alginate transdermal medicine delivery devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
AU646453B2 (en) * 1991-04-26 1994-02-24 Astra Aktiebolag Topical dressings
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
AU6491494A (en) * 1993-04-07 1994-10-24 Rexham Industries Corp. Method of coating microporous membranes and resulting products
CN1502331A (zh) 1993-07-19 2004-06-09 Ѫ�ܼ���ҩ�﹫˾ 抗血管生长组合物及使用方法
US5716981A (en) * 1993-07-19 1998-02-10 Angiogenesis Technologies, Inc. Anti-angiogenic compositions and methods of use
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
US5656279A (en) * 1994-02-23 1997-08-12 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
CN1170360A (zh) * 1994-12-21 1998-01-14 瑟垃技术有限公司 具有粘性贴面和剥离密封圆片的经皮输送系统
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US5780050A (en) 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5759560A (en) * 1995-07-27 1998-06-02 Bio Med Sciences, Inc. Silicone thermoplastic sheeting for scar treatment and useful article thereof; process of manufacture and use
US5733571A (en) * 1995-12-08 1998-03-31 Euro-Celtique, S.A. Transdermal patch for comparative evaluations
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
JP2001503749A (ja) * 1996-10-30 2001-03-21 セラテック・インコーポレーテッド 透過促進剤としてのグリコール酸の脂肪酸エステル及びその塩
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
PT1031347E (pt) 1999-01-27 2002-09-30 Idea Ag Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
WO2000054755A1 (en) * 1999-03-17 2000-09-21 Barbara Sheila Goldberg An adhesive dispensing arrangement
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
KR20020011437A (ko) * 1999-06-11 2002-02-08 추후보정 여성에 비-경구 안드로겐형 스테로이드의 투여
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
GB9917290D0 (en) * 1999-07-22 1999-09-22 Glaxo Wellcome Spa Pharmaceutical composition
EP1231877A4 (en) * 1999-11-04 2009-03-18 Xel Herbaceuticals TRANSDERMALE ADMINISTRATION OF HUPERZIN
US20050042271A1 (en) * 1999-11-19 2005-02-24 Xel Herbaceuticals, Inc . Transdermal delivery system for alkaloids of aconitum species
US6896898B1 (en) 1999-11-19 2005-05-24 Xel Herbaceuticals, Inc. Transdermal delivery system for alkaloids of aconitum species
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
FR2822711B1 (fr) 2001-03-28 2003-06-13 Oreal Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps
KR100438254B1 (ko) * 2001-03-29 2004-07-02 아이큐어 주식회사 비타민 ｄ 유사체를 포함하는 매트릭스형 경피흡수제제
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
CA2447302C (en) * 2001-05-01 2008-07-29 A.V. Topchiev Institute Of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8840918B2 (en) 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
RU2276998C2 (ru) * 2001-05-01 2006-05-27 Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук Гидрогелевые композиции
US8206738B2 (en) * 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US20050163829A1 (en) * 2001-12-07 2005-07-28 Norbert Hoenzelaer Device and patch for controlled release of vanillin
US7921999B1 (en) * 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
CA2453013C (en) * 2002-12-13 2011-02-15 Gary W. Cleary Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
US8524272B2 (en) 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US8784874B2 (en) * 2003-09-10 2014-07-22 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
UA84303C2 (ru) * 2003-10-28 2008-10-10 Новен Фармасьютикалз, Инк. Система для трансдермальной доставки лечебного средства
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
EP1713450B1 (en) 2004-01-30 2021-10-06 Corium, Inc. Rapidly dissolving film for delivery of an active agent
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
CN101039706A (zh) * 2004-08-05 2007-09-19 考里安国际公司 粘合剂组合物
US8343538B2 (en) * 2004-10-08 2013-01-01 Noven Pharmaceuticals, Inc. Compositions and methods for controlling the flux of a drug from a transdermal drug delivery systems
EP1811961A2 (en) * 2004-11-12 2007-08-01 Idea Ag Extended surface aggregates in the treatment of skin conditions
WO2006124584A2 (en) * 2005-05-13 2006-11-23 Alza Corporation Multilayer drug delivery system with barrier against reservoir material flow
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US10137135B2 (en) * 2005-08-15 2018-11-27 Allergan Sales, Llc Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
US7955677B2 (en) * 2005-12-07 2011-06-07 Mylan Technologies, Inc. Two-sided non-stick release film
AR063384A1 (es) 2006-10-25 2009-01-28 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
EP2738257A1 (en) 2007-05-22 2014-06-04 Amgen Inc. Compositions and methods for producing bioactive fusion proteins
WO2009009649A1 (en) 2007-07-10 2009-01-15 Agile Therapeutics, Inc. Dermal delivery device with in situ seal
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
WO2010036937A1 (en) 2008-09-27 2010-04-01 Taraxos Inc. Topical formulations for treatment of neuropathy
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
US8920392B2 (en) 2009-05-05 2014-12-30 Watson Laboratories, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
US9340590B2 (en) 2011-03-16 2016-05-17 Amgen Inc. Potent and selective inhibitors of NaV1.3 and NaV1.7
EP2765983A1 (de) 2011-10-11 2014-08-20 Hans Kosak Zusammensetzung zur einbringung von nukleinsäuren in zellen
US9656051B2 (en) 2011-12-01 2017-05-23 Avery Dennison Retail Information Services, Llc Devices with selectively permeable barriers
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
ES2699257T3 (es) 2013-02-28 2019-02-08 Dermira Inc Sales de glicopirrolato
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
WO2014165277A2 (en) 2013-03-12 2014-10-09 Amgen Inc. POTENT AND SELECTIVE INHIBITORS OF Nav1.7
US20150157509A1 (en) * 2013-12-11 2015-06-11 Oscar Polk Atkinson Occlusive skin covering
JP2020518325A (ja) * 2016-12-29 2020-06-25 ピュア レイシオス ホールディングス， インコーポレイテッド モジュール式経皮送達システムならびに製造および使用の関連する方法
US11318190B2 (en) 2017-05-05 2022-05-03 United States Government As Represented By The Department Of Veterans Affairs Methods and compositions for treating liver disease
KR20250067228A (ko) 2023-11-07 2025-05-15 김숙구 냉감성 항균 및 항염성 조성물, 냉감성 여성청결제 및 이의 제조방법
KR20250067227A (ko) 2023-11-07 2025-05-15 김숙구 열감성 항균 및 항염성 조성물, 열감성 여성청결제 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4696821A (en) * 1983-10-11 1987-09-29 Warner-Lambert Company Transdermal delivery system for administration of nitroglycerin
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
ES8608895A1 (es) * 1984-08-17 1986-07-16 Allpack Ind Lohnverpackung Parche adhesivo farmaceutico y procedimiento para su fabri- cacion
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
JPH0744940B2 (ja) * 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa

Also Published As

Publication number Publication date
KR0149492B1 (ko) 1998-10-01
AU631417B2 (en) 1992-11-26
US4983395A (en) 1991-01-08
DK0464106T3 (da) 1997-07-21
ATE154751T1 (de) 1997-07-15
KR920700019A (ko) 1992-02-19
CA2053272A1 (en) 1990-09-22
HK1003322A1 (en) 1998-10-23
CA2053272C (en) 1998-05-19
DE69030974T2 (de) 1997-12-18
DE69030974D1 (de) 1997-07-31
JPH04506062A (ja) 1992-10-22
EP0464106B1 (en) 1997-06-25
WO1990011065A1 (en) 1990-10-04
JPH0818976B2 (ja) 1996-02-28
EP0464106A1 (en) 1992-01-08
AU5341690A (en) 1990-10-22
EP0464106A4 (en) 1993-09-22

Similar Documents

Publication Publication Date Title
ES2035928T3 (es) Dispositivo para administrar un agente activo a la piel o a la mucosa.
DK0464106T3 (da) Anordning til indgivelse af et aktivt middel på hud eller slimhinder
US5415866A (en) Topical drug delivery system
US4573996A (en) Device for the administration of an active agent to the skin or mucosa
ES2044206T3 (es) Procedimiento para la obtencion de un sistema terapeutico transdermal en forma de un emplasto con varias capas.
US6120792A (en) Medicated skin patch and method for its use
JP3023989B2 (ja) 局所包帯剤、局所包帯剤の製造法および局所包帯剤の使用
JP4388068B2 (ja) 活性剤移動バリア層を含む経皮パッチ
GB8512358D0 (en) Transdermal delivery system
SE8605320D0 (sv) Therapeutic device for the administration of medicaments
ES2072397T3 (es) Metodo y dispositivo para la administracion transdermica de dexmedetomidina.
KR950007808A (ko) 약물투여용 의료용구
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
PT93431A (pt) Processo para a preparacao de um adesivo com a forma de sistema terapeutico transdermico para a administracao de substancias activas sobre a pele com uma libertacao de substancias actvas em fases
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
US3366112A (en) Adhesive bandage having container of liquid medicament
US3297032A (en) Adhesive bandage having container of medicament carried by removable protector strip
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
ES2058627T3 (es) Sistema terapeutico para la administracion retardada y dirigida a traves de la piel o de las mucosas de sustancias activas.
FI900315A0 (fi) Saett att framstaella ett ytligt terapeutiskt system vilket innehaoller tillvaext av elakartade celler och tillvaextfoerhindrande aktivaemne, speciellt 5-fluoruracil.
JPH06261954A (ja) 遠赤外線湿布材

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464106

Country of ref document: ES